Strategies delay-option

Most chemical companies that are not yet active in biotechnology should delay no longer, as the first movers have aheady started to reduce competitors options, and non-movers are unlikely to get a second chance. Some key developments in major areas and some approaches to strategy selection for the traditional chemical companies are outlined below. 

---